Natco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO, and what generic and branded alternatives to NATCO drugs are available?
NATCO has thirty-seven approved drugs.
There are three tentative approvals on NATCO drugs.
Summary for Natco
US Patents: | 0 |
Tradenames: | 34 |
Ingredients: | 34 |
NDAs: | 37 |
Patent Litigation for Natco: | See patent lawsuits for Natco |
Drugs and US Patents for Natco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 202595-001 | Aug 3, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 202595-003 | Aug 3, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco Pharma Ltd | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 207818-001 | Mar 1, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209555-001 | May 15, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco Pharma Ltd | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 208488-002 | Nov 5, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.